X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (375) 375
Publication (24) 24
Patent (6) 6
Book Chapter (5) 5
Book Review (3) 3
Book / eBook (1) 1
Conference Proceeding (1) 1
Newspaper Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (185) 185
male (149) 149
oncology (131) 131
middle aged (109) 109
aged (104) 104
index medicus (97) 97
cancer (78) 78
female (69) 69
chemotherapy (60) 60
treatment outcome (60) 60
adult (55) 55
prostate cancer (55) 55
urology & nephrology (52) 52
antineoplastic combined chemotherapy protocols - therapeutic use (50) 50
aged, 80 and over (48) 48
care and treatment (48) 48
prostatic neoplasms - drug therapy (44) 44
antineoplastic agents - therapeutic use (41) 41
research (38) 38
urology (37) 37
drug therapy (36) 36
metastasis (35) 35
carcinoma (34) 34
neoplasm metastasis (34) 34
survival (32) 32
docetaxel (31) 31
cisplatin (30) 30
prostate-specific antigen - blood (30) 30
carcinoma, renal cell - drug therapy (28) 28
prostatic neoplasms - pathology (28) 28
bladder cancer (27) 27
kidney neoplasms - drug therapy (27) 27
abridged index medicus (25) 25
carcinoma, renal cell (25) 25
clinical trials (25) 25
urinary bladder neoplasms - drug therapy (25) 25
vinblastine (24) 24
drug administration schedule (23) 23
therapy (23) 23
methotrexate (22) 22
disease-free survival (21) 21
medicine & public health (21) 21
urinary bladder neoplasms - pathology (21) 21
carcinoma, transitional cell - drug therapy (20) 20
trial (20) 20
antineoplastic agents (19) 19
antineoplastic combined chemotherapy protocols - adverse effects (19) 19
dosage and administration (19) 19
doxorubicin (19) 19
pharmacology & pharmacy (19) 19
sunitinib (19) 19
antineoplastic agents - adverse effects (18) 18
antimitotic agents (17) 17
article (17) 17
combined modality therapy (17) 17
health aspects (17) 17
interferon-alpha (17) 17
neoadjuvant therapy (17) 17
immunotherapy (16) 16
kidney neoplasms - pathology (16) 16
pharmacology/toxicology (16) 16
renal cell carcinoma (16) 16
disease progression (15) 15
dose-response relationship, drug (15) 15
mitoxantrone (15) 15
neoplasm staging (15) 15
patient outcomes (15) 15
prognosis (15) 15
prostatectomy (15) 15
antineoplastic agents - administration & dosage (14) 14
prostatic neoplasms, castration-resistant - drug therapy (14) 14
retrospective studies (14) 14
survival analysis (14) 14
castration (13) 13
cisplatin - administration & dosage (13) 13
patients (13) 13
prostate-specific antigen (13) 13
prostatic neoplasms - therapy (13) 13
transitional-cell carcinoma (13) 13
tumors (13) 13
endothelial growth-factor (12) 12
indoles - therapeutic use (12) 12
kaplan-meier estimate (12) 12
prednisone (12) 12
radical prostatectomy (12) 12
urinary bladder neoplasms - therapy (12) 12
urologic neoplasms - drug therapy (12) 12
urothelial carcinoma (12) 12
androgen antagonists - therapeutic use (11) 11
antigen (11) 11
cancer therapies (11) 11
cystectomy (11) 11
expression (11) 11
increased survival (11) 11
infusions, intravenous (11) 11
metastases (11) 11
neoadjuvant chemotherapy (11) 11
paclitaxel (11) 11
phase-ii trial (11) 11
prostatic neoplasms - surgery (11) 11
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Urology, ISSN 0090-4295, 09/2019, Volume 131, pp. 182 - 182
Journal Article
Urology, ISSN 0090-4295, 09/2019, Volume 131, p. 182
Journal Article
Urology, ISSN 0090-4295, 04/2017, Volume 102, pp. 157 - 158
Journal Article
Urology, ISSN 0090-4295, 04/2017, Volume 102, pp. 157 - 158
Journal Article
Urology, ISSN 0090-4295, 04/2017, Volume 102, pp. 157 - 158
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 08/2015, Volume 373, Issue 8, pp. 737 - 746
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2015, Volume 16, Issue 3, pp. 338 - 348
Summary Background Orteronel is an investigational, partially selective inhibitor of CYP 17,20-lyase in the androgen signalling pathway, a validated... 
Hematology, Oncology and Palliative Medicine | MITOXANTRONE | ONCOLOGY | MEN | END-POINTS | ABIRATERONE ACETATE | INCREASED SURVIVAL | DOCETAXEL | ENZALUTAMIDE | Steroid 17-alpha-Hydroxylase - antagonists & inhibitors | Prostatic Neoplasms, Castration-Resistant - enzymology | Humans | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Imidazoles - administration & dosage | Male | North America | Prostatic Neoplasms, Castration-Resistant - pathology | Time Factors | Prednisone - administration & dosage | Double-Blind Method | Europe | Risk Factors | Adenocarcinoma - enzymology | Kaplan-Meier Estimate | Proportional Hazards Models | Treatment Outcome | Prostatic Neoplasms, Castration-Resistant - drug therapy | Adenocarcinoma - drug therapy | Cytochrome P-450 Enzyme Inhibitors - administration & dosage | Adenocarcinoma - secondary | Disease Progression | New Zealand | Disease-Free Survival | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Asia | Naphthalenes - administration & dosage | Intention to Treat Analysis | Aged | Prostatic Neoplasms, Castration-Resistant - mortality | Steroid 17-alpha-Hydroxylase - metabolism | Australia | Adenocarcinoma - mortality | Medical colleges | Care and treatment | Chemotherapy | Corticosteroids | Cytochrome P-450 | Clinical trials | Prednisone | Metastasis | Prostate cancer | Cancer | Steroids
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2017, Volume 18, Issue 5, pp. 567 - 569
Journal Article
Lancet, The, ISSN 0140-6736, 2016, Volume 387, Issue 10031, pp. 1909 - 1920
Journal Article
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 07/2010, Volume 363, Issue 5, pp. 411 - 422
Journal Article
Lancet, The, ISSN 0140-6736, 2016, Volume 389, Issue 10064, pp. 67 - 76
Journal Article
Urology, ISSN 0090-4295, 02/2014, Volume 83, Issue 2, pp. 264 - 265
Journal Article
Urology, ISSN 0090-4295, 02/2014, Volume 83, Issue 2, pp. 264 - 265
Journal Article
Urology, ISSN 0090-4295, 02/2014, Volume 83, Issue 2, pp. 264 - 265
Journal Article
Urology, 09/2019, Volume 131, p. 182
Journal Article